Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Artificial Blood Substitutes Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Artificial blood substitutes have been a boon to many people in need of a transfusion. In the past, or rather, the past couple of years, many people who do not have access to a regular supply of blood have had to resort to using other means to get a little bit of life force. Moreover, artificial blood substitutes are designed to basically mimic the qualities and functions of human blood, they are not identical. Artificial blood is a great way to tide over during times of illness or injury. For these reasons, they are becoming increasingly popular as a result of a lack of access to blood products.
An increasing number of patient pools with intraoperative complications is driving the growth of artificial blood substitutes market. Moreover, the presence of a huge patient pool with various disorders such as neonatal conditions, CVDs, cancer, malignant neoplasms, and organ transplants is also contributing to the growth of the market. According to the National Health Council, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. More and more people are living with not just one chronic illness, such as diabetes, heart disease, or depression, but with two or more conditions. Furthermore, growing awareness regarding transfusion-transmitted diseases is further favoring the growth of artificial blood substitutes over the forecast period.
From the geographical point of view, North America is projected to gain significant growth over the forecast period and this is attributed to the increasing expenditure on the healthcare sector by government for improving patient care and treatment. According to the U.S. Centers for Medicare & Medicaid Services, the U.S. health care spending grew 4.6 percent in 2019, reaching $3.8 trillion or $11,582 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent
Key Developments:
- In September 2019, US-based KaloCyte, Inc, a preclinical-stage biotech firm, has been involved in the development of bio-inspired synthetic red blood cells (RBC) substitute.
- In October 2019, Scientists in Japan have developed “artificial blood” that could be transfused into patients regardless of their blood type
- In November 2017, SpheriTech, a life science company based at The Heath Business and Technical Park in Runcorn, has been awarded a grant from innovation agency Innovate UK to help fund a £100k pioneering research project to develop artificial blood
The Artificial Blood Substitutes Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Artificial Blood Substitutes Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Aurum Biosciences Ltd.
- HEMARINA SA
- Hemoglobin Oxygen Therapeutics LLC
- KaloCyte Inc.
- SpheriTech Ltd.
- ...
By the Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
- Hospital
- Clinic
- Research Institute
- Other
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Artificial Blood Substitutes Market Report:
- To assess the size of the market by value and volume
- Analyze the Artificial Blood Substitutes Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Artificial Blood Substitutes Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Artificial Blood Substitutes Market
The Artificial Blood Substitutes Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Artificial Blood Substitutes Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
